AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 88.00
-0.80 (-0.90%)
Jul 30, 2026, 9:58 AM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 8.61 billion as of July 29, 2026. Its market cap has increased by 45.81% in one year.
Market Cap
8.61B
Enterprise Value
7.57B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
88.00
ChartMarket Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 8.61B, an increase of 69.03%. That is a compound annual growth rate of 18.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 8.61B | -43.78% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 13.17B |
| Tanvex BioPharma | 10.18B |
| Gongwin Biopharm Holdings | 9.88B |
| Polaris Group | 9.85B |
| PharmaEngine | 9.24B |
| Locus Cell | 7.60B |
| Acepodia | 7.23B |
| Adimmune | 7.06B |